PL376441A1 - Awirulentna postać wirusa powodującego choroby ryb, sposób otrzymywania oraz zastosowanie awirulentnej formy wirusa, kompozycja i zestaw do szczepienia obejmujący awirulentną formę wirusa - Google Patents

Awirulentna postać wirusa powodującego choroby ryb, sposób otrzymywania oraz zastosowanie awirulentnej formy wirusa, kompozycja i zestaw do szczepienia obejmujący awirulentną formę wirusa

Info

Publication number
PL376441A1
PL376441A1 PL37644103A PL37644103A PL376441A1 PL 376441 A1 PL376441 A1 PL 376441A1 PL 37644103 A PL37644103 A PL 37644103A PL 37644103 A PL37644103 A PL 37644103A PL 376441 A1 PL376441 A1 PL 376441A1
Authority
PL
Poland
Prior art keywords
viral infection
against viral
fish against
immunizing fish
immunizing
Prior art date
Application number
PL37644103A
Other languages
English (en)
Other versions
PL209978B1 (pl
Inventor
Moshe Kotler
Ayana Benet
Izhak Bejerano
Nissim Chen
Marina Hutoran
Ariel Ronen
Original Assignee
Yissum Research Development Company Of The Hebrewuniversity Of Jerusalem
Ministry Of Agriculture And Rural Development Dept.Of Fisheries And Aquaculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Research Development Company Of The Hebrewuniversity Of Jerusalem, Ministry Of Agriculture And Rural Development Dept.Of Fisheries And Aquaculture filed Critical Yissum Research Development Company Of The Hebrewuniversity Of Jerusalem
Publication of PL376441A1 publication Critical patent/PL376441A1/pl
Publication of PL209978B1 publication Critical patent/PL209978B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00061—Methods of inactivation or attenuation
    • C12N2710/00064—Methods of inactivation or attenuation by serial passage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)
  • Feed For Specific Animals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL376441A 2003-01-01 2003-12-22 Awirulentna postać wirusa DNA karpia powodującego wirusową chorobę ryb, sposób wyodrębniania żywego atenuowanego wirusa DNA karpia, żywy atenuowany wirus karpia otrzymany tym sposobem, sposób diagnozowania choroby związanej z wirusem DNA karpia, szczepionka i zastosowanie szczepionki, oraz zestaw zawierający żywe atenuowane wirusy PL209978B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15377503A IL153775A0 (en) 2003-01-01 2003-01-01 Immunizing fish against viral infection
PCT/IL2003/001097 WO2004061093A1 (en) 2003-01-01 2003-12-22 Immunizing fish against viral infection

Publications (2)

Publication Number Publication Date
PL376441A1 true PL376441A1 (pl) 2005-12-27
PL209978B1 PL209978B1 (pl) 2011-11-30

Family

ID=29798413

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376441A PL209978B1 (pl) 2003-01-01 2003-12-22 Awirulentna postać wirusa DNA karpia powodującego wirusową chorobę ryb, sposób wyodrębniania żywego atenuowanego wirusa DNA karpia, żywy atenuowany wirus karpia otrzymany tym sposobem, sposób diagnozowania choroby związanej z wirusem DNA karpia, szczepionka i zastosowanie szczepionki, oraz zestaw zawierający żywe atenuowane wirusy

Country Status (12)

Country Link
US (1) US7351527B2 (pl)
EP (1) EP1578959B1 (pl)
JP (2) JP4690049B2 (pl)
CN (1) CN100535108C (pl)
AT (1) ATE507286T1 (pl)
AU (1) AU2003288510A1 (pl)
DE (1) DE60336927D1 (pl)
DK (1) DK1578959T3 (pl)
IL (2) IL153775A0 (pl)
PL (1) PL209978B1 (pl)
RU (1) RU2369635C2 (pl)
WO (1) WO2004061093A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109114B2 (ja) * 2006-02-24 2012-12-26 国立大学法人三重大学 魚類抗体産生の新規検出法
CN101495636B (zh) * 2006-04-13 2012-12-05 国立大学法人东京海洋大学 锦鲤疱疹病毒（khv）病用dna疫苗
JP5567244B2 (ja) * 2006-06-06 2014-08-06 共立製薬株式会社 魚類ストレプトコッカス・ディスガラクティエを抗原とする不活化ワクチン
EP2031065A1 (en) * 2007-08-28 2009-03-04 Université de Liège A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi
MX2010002122A (es) * 2007-08-28 2010-07-06 Univ Liege Un herpesvirus koi(khv) recombinante (khv) o cyprinid herpesvirus 3 (cyhv-3) y una vacuna para la prevencion de una enfermedad causada por khv/cyhv-3 en carpa comun o carpa comun koi.
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5462518B2 (ja) * 2009-04-09 2014-04-02 公益財団法人ヒューマンサイエンス振興財団 抗体精製方法
EP2487241A1 (en) 2011-02-09 2012-08-15 Westfälische Wilhelms-Universität Münster RNAi agents and compositions useful as carp therapeutics
UA114719C2 (uk) * 2011-12-30 2017-07-25 Гесваль С.А. Рекомбінантний герпесвірус кої (khv) і вакцина для профілактики захворювання, що викликається khv
RU2663244C2 (ru) * 2013-03-15 2018-08-03 Атлантиум Текнолоджиз Лтд. Система и способ для инактивации вируса инфекционного панкреатического некроза (ipnv) посредством оптимизированного ультрафиолетового излучения
WO2014185439A1 (ja) * 2013-05-15 2014-11-20 独立行政法人水産総合研究センター コイ科ヘルペスウイルス－２（Ｃｙｐｒｉｎｉｄ ｈｅｒｐｅｓｖｉｒｕｓ－２：ＣｙＨＶ－２）感染症用ワクチンおよびその製造方法、ならびにＣｙＨＶ－２ウイルス製造方法
CN103430936A (zh) * 2013-09-06 2013-12-11 中国水产科学研究院黑龙江水产研究所 一种用于鱼类基因组dna提取的鱼鳍组织的制备方法
IL230970A0 (en) * 2014-02-13 2014-09-30 Univ Ramot Tilapia virus vaccines
CN104774802B (zh) * 2015-04-27 2017-12-08 上海海洋大学 银鲫鱼背鳍细胞系
RU2640346C1 (ru) * 2016-08-11 2017-12-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Государственный аграрный университет Северного Зауралья" (ФГБОУ ВО ГАУ Северного Зауралья) Способ антиоксидантной защиты мальков карпа
WO2020127941A2 (en) 2018-12-21 2020-06-25 Intervet International B.V. Serum free intracellular pathogen vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
IL169412A (en) 2011-04-28
IL153775A0 (en) 2003-07-31
PL209978B1 (pl) 2011-11-30
RU2369635C2 (ru) 2009-10-10
WO2004061093A1 (en) 2004-07-22
JP2011024584A (ja) 2011-02-10
AU2003288510A1 (en) 2004-07-29
DE60336927D1 (pl) 2011-06-09
JP2006512078A (ja) 2006-04-13
US7351527B2 (en) 2008-04-01
EP1578959A1 (en) 2005-09-28
CN1742083A (zh) 2006-03-01
RU2005120158A (ru) 2006-01-20
DK1578959T3 (da) 2011-08-15
AU2003288510A8 (en) 2004-07-29
JP4690049B2 (ja) 2011-06-01
EP1578959B1 (en) 2011-04-27
US20060013828A1 (en) 2006-01-19
CN100535108C (zh) 2009-09-02
ATE507286T1 (de) 2011-05-15

Similar Documents

Publication Publication Date Title
IL153775A0 (en) Immunizing fish against viral infection
MXPA05009580A (es) Vacuna contra el virus de la influenza.
PH12019501766A1 (en) Porcine coronavirus vaccines
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
DK1147117T3 (da) Immunologiske adjuvansforbindelser
ATE426412T1 (de) Adjuvante influenza-vakzine
EP1220925B8 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
DK1409692T3 (da) Nye peptider afledt af G-proteinet fra RSV, og anvendelse heraf i en vaccine
DE60115051D1 (de) Immunologische adjuvans verbindungen
DE60222296D1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
SE9903534D0 (sv) Vaccin
WO2003103570A3 (en) Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
MA37432A1 (fr) Virus modifié de la maladie de marek, et vaccins préparés à partir de celui-ci
UA86405C2 (ru) Способ вакцинации против инфекции семенников, вызванной вирусом бычьей вирусной диареи
ATE424844T1 (de) Kombinationsvakzine für geflügel
DE602004028512D1 (de) Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus
HUP0402548A2 (hu) Madárembrió-részecskékből álló biomassza vírusantigének előállítására
UA4626U (uk) Бівалентна інактивована концентрат-вакцина проти інфекційного ринотрахеїту та вірусної діареї великої рогатої худоби
UA62746C2 (en) Emulsion vaccine associated inactivated against newcastle disease, infectious bronchitis of fowls, and syndrome of decreasing egg production-76
WO2006098769A3 (en) Multipathogen and monopathogen protection against the bacterial and viral infections associated with biological warfare, cardiac diseases, and cancers
UA6072U (en) Inactivated vaccine against viral diarrhea of the cattle
CY1116907T1 (el) Ανασυνδυασμενα εμβολια κατα κωπηποδων καλιγιδων (θαλασσιων ψειρων) και αλληλουχιες αντιγονων αυτων